347 related articles for article (PubMed ID: 19458650)
21. Retinal Structure and Gene Therapy Outcome in Retinoschisin-Deficient Mice Assessed by Spectral-Domain Optical Coherence Tomography.
Zeng Y; Petralia RS; Vijayasarathy C; Wu Z; Hiriyanna S; Song H; Wang YX; Sieving PA; Bush RA
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT277-87. PubMed ID: 27409484
[TBL] [Abstract][Full Text] [Related]
22. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis.
Min SH; Molday LL; Seeliger MW; Dinculescu A; Timmers AM; Janssen A; Tonagel F; Tanimoto N; Weber BH; Molday RS; Hauswirth WW
Mol Ther; 2005 Oct; 12(4):644-51. PubMed ID: 16027044
[TBL] [Abstract][Full Text] [Related]
23. Effect of late-stage therapy on disease progression in AAV-mediated rescue of photoreceptor cells in the retinoschisin-deficient mouse.
Janssen A; Min SH; Molday LL; Tanimoto N; Seeliger MW; Hauswirth WW; Molday RS; Weber BH
Mol Ther; 2008 Jun; 16(6):1010-7. PubMed ID: 18388913
[TBL] [Abstract][Full Text] [Related]
24. Retinal organoids with X-linked retinoschisis RS1 (E72K) mutation exhibit a photoreceptor developmental delay and are rescued by gene augmentation therapy.
Duan C; Ding C; Sun X; Mao S; Liang Y; Liu X; Ding X; Chen J; Tang S
Stem Cell Res Ther; 2024 May; 15(1):152. PubMed ID: 38816767
[TBL] [Abstract][Full Text] [Related]
25. Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial.
Mishra A; Vijayasarathy C; Cukras CA; Wiley HE; Sen HN; Zeng Y; Wei LL; Sieving PA
Mol Ther; 2021 Jun; 29(6):2030-2040. PubMed ID: 33601057
[TBL] [Abstract][Full Text] [Related]
26. X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.
Molday RS; Kellner U; Weber BH
Prog Retin Eye Res; 2012 May; 31(3):195-212. PubMed ID: 22245536
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
28. Rs1h
Zeng Y; Qian H; Campos MM; Li Y; Vijayasarathy C; Sieving PA
Gene Ther; 2022 Aug; 29(7-8):431-440. PubMed ID: 34548657
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results.
Pennesi ME; Yang P; Birch DG; Weng CY; Moore AT; Iannaccone A; Comander JI; Jayasundera T; Chulay J;
Ophthalmol Retina; 2022 Dec; 6(12):1130-1144. PubMed ID: 35781068
[TBL] [Abstract][Full Text] [Related]
30. Rearing Light Intensity Affects Inner Retinal Pathology in a Mouse Model of X-Linked Retinoschisis but Does Not Alter Gene Therapy Outcome.
Marangoni D; Yong Z; Kjellström S; Vijayasarathy C; A Sieving P; Bush RA
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1656-1664. PubMed ID: 28297725
[TBL] [Abstract][Full Text] [Related]
31. The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-h
Hassan S; Hsu Y; Thompson JM; Kalmanek E; VandeLune JA; Stanley S; Drack AV
Front Med (Lausanne); 2024; 11():1304819. PubMed ID: 38414621
[TBL] [Abstract][Full Text] [Related]
32. The X-linked juvenile retinoschisis protein retinoschisin is a novel regulator of mitogen-activated protein kinase signalling and apoptosis in the retina.
Plössl K; Weber BH; Friedrich U
J Cell Mol Med; 2017 Apr; 21(4):768-780. PubMed ID: 27995734
[TBL] [Abstract][Full Text] [Related]
33. Genetic modification of the schisis phenotype in a mouse model of X-linked retinoschisis.
Johnson BA; Aoyama N; Friedell NH; Ikeda S; Ikeda A
Genetics; 2008 Mar; 178(3):1785-94. PubMed ID: 18245825
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.
Vijayasarathy C; Sui R; Zeng Y; Yang G; Xu F; Caruso RC; Lewis RA; Ziccardi L; Sieving PA
Hum Mutat; 2010 Nov; 31(11):1251-60. PubMed ID: 20809529
[TBL] [Abstract][Full Text] [Related]
35. Photoreceptor deficits appear at eye opening in Rs1 mutant mouse models of X-linked retinoschisis.
Tarchick MJ; Beight C; Bonezzi PB; Peachey NS; Renna JM
Exp Eye Res; 2024 May; 242():109872. PubMed ID: 38514024
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal Injection of an Exosome-Associated Adeno-Associated Viral Vector Enhances Retinoschisin 1 Gene Transduction in the Mouse Retina.
Wang W; Liu J; Yang M; Qiu R; Li Y; Bian S; Hao B; Lei B
Hum Gene Ther; 2021 Jul; 32(13-14):707-716. PubMed ID: 33832349
[TBL] [Abstract][Full Text] [Related]
37. Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis.
Sergeev YV; Caruso RC; Meltzer MR; Smaoui N; MacDonald IM; Sieving PA
Hum Mol Genet; 2010 Apr; 19(7):1302-13. PubMed ID: 20061330
[TBL] [Abstract][Full Text] [Related]
38. Pathomechanism of mutated and secreted retinoschisin in X-linked juvenile retinoschisis.
Plössl K; Schmid V; Straub K; Schmid C; Ammon M; Merkl R; Weber BHF; Friedrich U
Exp Eye Res; 2018 Dec; 177():23-34. PubMed ID: 30040949
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal injection of new adeno-associated viral vector: Enhancing retinoschisin 1 gene transduction in a mouse model of X-linked retinoschisis.
Sun Y; Xiao D; Li Z; Xu D; Zhang D; An Y; Xue J; Ren Y; Liu S; Wang D; Li J; Wang Z; Pang J
Biochem Biophys Rep; 2024 Mar; 37():101646. PubMed ID: 38333050
[TBL] [Abstract][Full Text] [Related]
40. Clinical manifestation and current therapeutics in X-juvenile retinoschisis.
Yang YP; Jheng YC; Chien Y; Tsai PH; Hwang DK; Weng CC; Huang YM; Hsu CC; Chou YB; Chen SJ; Lin TC
J Chin Med Assoc; 2022 Mar; 85(3):276-278. PubMed ID: 35259130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
